REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,180
-80 (-0.71%)
Apr 28, 2026, 3:30 PM KST
-2.19%
Market Cap 205.05B
Revenue (ttm) 145.93B
Net Income (ttm) -29.63B
Shares Out 18.34M
EPS (ttm) -1,616.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,258
Average Volume 38,411
Open 11,260
Previous Close 11,260
Day's Range 11,100 - 11,410
52-Week Range 9,580 - 14,430
Beta 0.56
RSI 67.92
Earnings Date May 15, 2026

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 448
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.